Sunshine Biopharma, Inc. (NASDAQ: SBFM) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $5.96 million versus the consensus estimate of $6 million.

For earnings history and earnings-related data on Sunshine Biopharma, Inc. (SBFM) click here.